Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Voyageur Pharmaceuticals Ltd VYYRF


Primary Symbol: V.VM

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > Rain Cage Billion$ deal
View:
Post by biggdogg on May 09, 2024 12:08pm

Rain Cage Billion$ deal

This is a significant deal for RC, they are replacing fossil fuel power with advanced carbon batteries. https://www.africa-newsroom.com/press/transforming-emissions-into-power-clg-advises-on-sapele-power-plc-and-africa--rain-cage-ltds-deal-for-pioneering-renewable-energy-solutions-in-africa?lang=en
This unique carbon that Voyaguer will be farming will be used to make their Knight’s Charge DC units. They are converting 1000MW, that is a huge project.
Comment by WarrantOfficer on May 10, 2024 9:43am
RC technology should be a game changer. Voyaguer plans to utilize RC technology for a new line of fullerene contrast media utilizing the exhaust from a future phrama manufacturing facility that they will build or buy. Has Voyaguer articulated the transfer of carbon based fullerene from the first EDEN  systems to assist in accelerating fullerene contrast media R&D? We could be years ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities